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Abstract
Background: Childhood obesity is a major global public health problem, with governments increasingly having to
undertake various strategies to reduce excess weight in their populations. Considering the increasing number of
well-conducted intervention studies in the field of childhood obesity prevention, there are relatively few published
economic evaluations. The proposed systematic review will explore the methods of these economic evaluations,
examine the limitations and establish the evidence base for cost-effectiveness analyses.
Methods/design: Systematic review methodology will be applied to identify, select and extract data from published
economic evaluation studies (trial-based, non-trial based, simulation-based, decision model and trial based model
economic evaluations) of obesity prevention and/or treatment interventions in children and adolescents. A systematic
literature search will be conducted using bibliographic databases (MEDLINE, EMBASE, CINAHL, Web of Science, EconLit,
PsycINFO, Cochrane Library, Centre for Reviews and Dissemination (CRD) and Cost-Effectiveness Analysis (CEA)
Registry). The review will only include full economic evaluations. There will be no restrictions based on language,
perspective, follow-up duration, sample size, country or setting. To minimise selection bias, translation of non-English
language articles will be undertaken. The quality of included studies will be assessed. Following data extraction, a
narrative synthesis of the results from the included studies will be undertaken. Subgroup analysis will be considered
where deemed appropriate.
Discussion: The findings from this review, which will include primary studies, will provide evidence to assist health policy
decision makers interpret economic evaluations in this field. In addition, we will identify gaps in the current literature to
inform future-related research.
Systematic review registration: Prospero CRD42017062236
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Background
Childhood obesity is a major global public health problem,
which leads to health, social and emotional problems, as
well as associated high health care costs [1]. Thus, govern-
ments and policy makers are increasingly seeking to ad-
dress this issue through a variety of strategies [2]. Over the
last 3 decades, the percentage of people who are overweight
or obese has been increasing globally [3]. Estimated age-
standardised prevalence of obesity in children and adoles-
cents in 2016 ranged from higher than 30% in, for example,
Nauru, the Cook Islands, and Palau to lower than 2% in
other countries, including Ethiopia [4]. Obesity is as much
an issue in developing as in developed countries. Although
the prevalence of childhood obesity may be higher in devel-
oped countries, the rate of increase over the last decade is
steeper in many developing countries [4].
Children who are overweight or obese run an increased
risk of becoming obese in adulthood with the associated
adverse health effects. However, even during childhood,
they are more likely to develop early symptoms and signs
of co-morbidities, hypertension and insulin resistance [5].
The increasing prevalence of childhood obesity is also a
major economic concern. Obesity leads to significant eco-
nomic and societal consequences via both direct and indir-
ect costs [6, 7]. Directs costs relate to the healthcare needs
arising from the related health problems, whilst indirect
costs, which are estimated to even exceed the direct costs,
are a result of productivity losses (sick leave, disability, pre-
mature death) [7, 8]. Also, lower academic achievement
among children with overweight and obesity could hinder
their future employment prospects [5]. Obesity prevention
and treatment in children and adolescents is therefore a
key public health priority. However, despite the increasing
number of intervention studies, there are relatively few
published economic evaluations [9–11].
The concept of opportunity cost plays a fundamental
role in the economist’s view of costs. In many countries,
the scarcity of economic resources relative to needs re-
quires decision makers to prioritise spending in the know-
ledge that the use of resources in one way prevents their
use in others [12]. They need to invest in initiatives which
offer the best value for money from increasingly limited
public resources [13]. Economic evaluation is a means to
aid decisions about public resource allocation to maximise
society’s welfare [3, 13]. To reflect a societal cost, where
possible, all resource use should be measured, outlining
how costs fit within a given sector, such as health, trans-
port, education or the wider community [14]. The UK
Treasury guidance distinguishes between reporting ac-
counting costs, to understand the flow of expenditure and
resources, and reporting opportunity costs, reflecting the
wider costs and benefits of interventions [15]. Opportun-
ity cost can be assessed directly with cost utility or cost-
effectiveness studies [12].
Although the concept of opportunity cost is important,
there can be a number of challenges with applying it within
the context of economic evaluation [12]. For example, the
perspective of the study is important as this determines
which costs and effects are included and the choice
of comparisons are crucial in that these reflect the
outcomes forgone from alternative uses of the limited
resources. However, when incorporating costs and out-
comes that span across multiple sectors as is commonly
the case within obesity interventions, it is not always clear
what society’s willingness to pay is for a non-health effect
caused by a health-focused intervention or funded from a
‘health care budget’, or what the opportunity cost is of
non-health resources, e.g. the value of a pound within
the education sector. Also, valuation of resources for
which no market exists, such as informal care, or patient
time costs, requires specific methods [12]. Due to such
challenges, few studies are ever completely explicit about
their estimates of opportunity costs.
Discounting enables a comparison between interven-
tions that lead to benefits and incur costs over a number
of years [16]. Currently, NICE recommends a discount
rate of 3.5% per year for both costs and outcomes [17].
For childhood obesity prevention interventions, the ef-
fect of discounting will cause future health gains to be
devalued [13]. However, failure to discount future bene-
fits would consider interventions to be more cost effect-
ive than they would otherwise appear [18].
Seven recent reviews [5, 19–24] have summarised the
cost-effectiveness of obesity prevention and/or treatment
interventions in young people; however, none have used
or reported rigorous methods for conducting their reviews.
Only two of them consider accounting for costs occurring
across different sectors [5, 23]. Five of the previous reviews
had restrictions based on language criteria [5, 19–21, 23]
and four of the previous reviews explicitly excluded studies
that were conducted in developing countries within their
exclusion criteria [5, 19, 21, 23]. Only three of the reviews
used established criteria, e.g. Drummond or Philips to
assess the quality of the primary studies, and used pre-
ventative steps to minimise bias and errors in the qual-
ity assessment process [5, 20, 23]. The search strategy
was adequate and appropriate in over half of the reviews
(4/7) [5, 20, 22, 23]. However, several more relevant data-
bases could have been searched to ensure that all studies
were identified. Further, the latest date that the previous
published reviews covered was up to November 2015
and, since then, at least 3 new economic evaluation
studies of childhood obesity interventions have been
published [25–27].
One recent review paper on child and adolescent obesity
summarised the findings from 21 obesity prevention studies
that included economic evaluation [24]. The authors
found that 6 interventions were dominant, in that the
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interventions are likely to result in both health gains
and real cost savings to health services or to society; 12
were likely to be cost-effective, in that financial costs
are worthwhile for the health gains and 3 were unlikely
to be cost-effective. However, this brief summary did
not critique the methods used for economic evaluation.
A further review of 8 cost-effectiveness analysis studies
of childhood obesity prevention, which included a subset
of the 21 studies reviewed in the other review, found
that 1 intervention was dominant; 4 were likely to be cost-
effective and 3 were unlikely to be cost-effective [20].
However, this review also did not provide information re-
garding how opportunity cost was valued, and what per-
spective was adopted for economic evaluation.
A review of the methods used within 6 published eco-
nomic evaluations of obesity prevention studies in early
childhood (preschool children (< 6 years)) limited inclusion
criteria to trials that included specific outcome measures
(at least one of the following: BMI, waist circumference or
overweight prevalence) [5]. Furthermore, all included stud-
ies were based on behavioural interventions that targeted
both diet and physical activity but none that targeted either
diet or physical activity alone. It found that 3 interventions
were cost-effective and 1 was not cost-effective.
Another review focused on economic evaluations of
physical activity programmes as a primary prevention
approach for obesity in children and adolescents [23].
This did not provide detailed information about the
numbers of interventions that were cost-effective. A re-
view of childhood obesity interventions in Australia sum-
marised the findings from 13 community, behavioural,
pharmaceutical and surgical interventions and assessed
their cost-effectiveness [19]. In line with the Assessing
Cost-Effectiveness (ACE) obesity approach [28], all in-
cluded studies followed the same methodology for the
economic evaluation allowing a comparison of cost-
effectiveness between interventions. Similar to the pre-
vious reviews, the authors did not critically assess the
methods used for economic evaluation.
A similar approach to the Australian review was applied
in another review, in which the ACE approach was adapted
to the US setting [21]. Purposive sampling of intervention
studies was applied to represent a ‘broad range of national
scalable interventions’, including 4 intervention studies.
Another review focused on cost of illness and cost-
effectiveness of childhood obesity interventions [22].
This review also did not provide information regarding
the methods to value opportunity cost, or the perspective
for the evaluation.
In summary, none of the existing reviews considered
issues associated with the characteristics of the economic
methods used, such as methods for collecting resource
use data, how opportunity cost has been captured, report-
ing the largest cost drivers which impact upon cost-
effectiveness and critiquing the modelling methods where
appropriate. Also, there are no review studies addressing
the question of how methods vary by setting, country,
type of intervention or over time. These issues are import-
ant to consider when reviewing cost-effectiveness evidence
[16]. It is for these reasons that a new systematic review
will be conducted. The aim of this review is to critique the
methods used in economic evaluations of child and ado-
lescent obesity and summarise cost-effectiveness evalua-
tions of prevention and treatment interventions. Primary
economic evaluation studies will be included, with no re-
strictions on the setting, language or country.
Methods/design
Objectives (s)
The primary objective is to systematically review methods
of economic evaluations of obesity prevention and/or treat-
ment interventions in children and adolescents. The review
will examine the limitations and establish the evidence
base for cost-effectiveness, focusing on methods for col-
lecting resource use, valuing opportunity costs, methods
for reporting costs and effectiveness across health and
non-health settings, measures of effectiveness, and where
appropriate, a critical review of decision-analytic models.
A secondary objective is to determine how the methods
(in terms of perspective, costs included, outcomes and
method of assessing cost-effectiveness) vary by setting,
country, type of intervention or time period of the study
with reference to any guidelines from the country in which
the study is set.
The guidelines by the Cochrane Collaboration for Re-
views and Centre for Reviews and Dissemination (CRD)
will be followed in the systematic review [29, 30]. The
systematic review protocol has been registered with the
international prospective register of systematic reviews
(PROSPERO) database ref. (CRD42017062236) and has
been reported according to the PRISMA-P guidelines
(see Additional file 1).
Selection criteria
Since the objective of the systematic review will be to
critique the methods used in economic evaluations of child
and adolescent obesity and summarise cost-effectiveness
evaluations of prevention and treatment interventions,
studies will be included in the review if they meet the
following criteria:
Types of study to be included
Full economic evaluations (studies in which both the
costs and outcomes of the alternatives are examined and
in which a comparison of two or more interventions or
case alternatives is undertaken) including:
Primary economic evaluation studies including:
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 Trial-based
 Non-trial based
 Simulation-based
 Decision model
 Trial-based model
Qualitative studies, conference abstracts, short notes,
comments, editorials and study protocols will be excluded.
Partial economic evaluations will also be excluded because
the review will synthesise the evidence base for cost-
effectiveness and provide an assessment of methods for
full economic evaluations.
Condition or domain being studied
Condition or domain being studied is overweight or
obesity in children and adolescents.
Participants/population
Children and adolescents aged 0–19 years at the start of
the intervention and/or their parents/guardians will be in-
cluded. Family based interventions will be included, in
which case, the target participants will be the children.
There will be no restrictions on participant characteristics
such as gender, baseline weight status or country. Both de-
veloped and developing countries will be included. Any
interventions to tackle obesity due to a secondary cause
(i.e. Prader-Willi syndrome) will not be included.
Intervention(s) and exposure(s)
Any behavioural, community, policy or environmental
interventions aimed at the treatment or prevention of
overweight/obesity in children and/or adolescents will
be included. Considering that prevention and treatment
interventions are likely to be diverse the findings will be
synthesised separately for both types of interventions
and compared and contrasted if relevant. Pharmacological
or surgical interventions will not be included.
Comparator(s)/control
There will be no restrictions on the types of comparator(s).
For example, the comparator can be either no intervention
or another intervention. However, the study should have a
clear definition of the comparison.
Outcome(s)
Primary outcomes There will be no restrictions on study
outcomes because the purpose of the review is to assess
what outcomes are reported within economic evaluations.
However, potentially relevant primary outcomes will be
disability-adjusted life years (DALYs), quality-adjusted
life years (QALYs), effectiveness outcomes such as kilo-
gramme (kg) weight loss, % body fat, BMI (z score), waist
circumference, skinfold thickness, overweight and obesity
case avoided, additional minute of MVPA, increase in
physical activity and MET hour gained.
Secondary outcomes All outcomes as mentioned above.
Other criteria
There will be no restrictions based on language, perspec-
tive, follow-up duration, sample size or setting. Studies
will be sought if published between January 2001 and
the date of the searches. The year 2001 is chosen since
the first study evaluating the cost-effectiveness of a
childhood obesity treatment intervention was published
in 2001, followed 2 years later by the first economic
evaluation of a childhood obesity prevention interven-
tion [22]. The searches will be re-run just before the
final analyses and further studies retrieved for inclusion.
Search strategy
The following electronic bibliographic databases of pub-
lished studies will be searched:
 MEDLINE (Ovid)
 EMBASE (Ovid)
 Web of Science
 CINAHL Plus
 EconLit
 PsycINFO
 Cochrane Central Register of Controlled Trials
(CENTRAL) and Cochrane Database of Systematic
Reviews (CDSR)
 Centre for Reviews and Dissemination (CRD)
Databases (Database of Abstracts of Reviews of
Effects (DARE), the National Health Service
Economic Evaluation Databases (NHS EED), Health
Technology Assessment Database (HTA))
 Cost-Effectiveness Analysis (CEA) Registry
In addition, the following sources will also be used to
identify potential additional studies, including grey lit-
erature sources for review:
 Citation tracking in Google Scholar to retrieve
further references.
 Searching the relevant National Institute for Health
and Care Excellence (NICE) guidelines.
 The systematic scanning of the reference lists of
eligible studies and review articles.
 Contact with study authors where appropriate.
 Grey literature such as OpenSIGLE, National
Obesity Observatory, NHS Evidence, National
Technical Information Service, Healthcare
Management Information Consortium (HMIC) and
RePEC (Economic Working papers) database.
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Potential search terms
The potential search terms are systematic review, eco-
nomic evaluation, cost-effectiveness, obesity, children,
adolescents, prevention, treatment and intervention.
A Subject Advisor for Medicine and an Information
Specialist applied a search strategy for MEDLINE, which
was based on medical subject headings (MeSH) terms
and text words of key papers that were identified before-
hand (see Additional file 2). The search terms and text
words will be adapted for use with other bibliographic
databases.
The literature search results will be managed using
Endnote 7 (Thomson Reuters) to facilitate removal of du-
plicate records, study selection, recording decisions and
references.
Study selection procedure
The review will follow a two-stage method. Paper selec-
tion will be based on the inclusion and exclusion criteria:
 First, two reviewers will independently screen titles
and abstracts against the selection criteria.
 Second, where there is doubt, the full-text version
will be requested. All full-text papers will be further
reviewed by two reviewers and a final decision made
with respect to the inclusion/exclusion criteria.
Any disagreement or conflicting views between the
reviewers over the eligibility of specific studies will be
resolved by discussion or the final judgement of a third
reviewer. Both stages of the selection process will be
piloted and if necessary modified.
A PRISMA flow diagram will be used to illustrate the
study selection processes [31]. Details of articles excluded
at the second stage will be recorded along with the reason
for exclusion [31]. To aid study selection and analysis of
non-English language articles, translation either in part or
in whole will be undertaken by appropriate University
members. Endnote will be used to keep track of references.
Data extraction
Publication information, study characteristics and find-
ings from the included studies, related to the research
question, will be recorded in a standardised, pre-piloted
data extraction form using Excel. Extracted information
will include:
 Authors
 Publication year
 Country
 Currency unit
 Study design
 Setting
 Target population
 Sample size
 Overview and aim of the intervention
 Comparator
 Measures of effectiveness
 Model specification
 Study perspective
 Length of follow-up
 Time horizon
 Methods for collecting resource use
 Price year
 Costs categories
 Largest cost drivers
 Opportunity cost
 Excluded costs
 Discount rate
 Total/average intervention costs
 ICER
 Uncertainty analysis
 Sensitivity analysis
 Funding source
The main reviewer will extract the data. To validate the
data extraction process, the process will be independently
checked for completeness and accuracy by a second re-
viewer. Any discrepancies between the reviewers over the
data extraction process will be identified and resolved by
discussion or the final judgement of a third reviewer.
Missing data will be requested from study authors.
Quality assessment of included studies
For this review, the Drummond checklist is not compre-
hensive enough to assess the quality of the economic evalu-
ation studies included [16]. However, the Philips checklist is
only applicable for modelling studies [32]. Therefore, the
quality assessment checklist developed by the Centre for
Reviews and Dissemination of the University of York,
which is a slightly adapted version of the Drummond
checklist, will be used [33]. A few extra questions that are
relevant to a paediatric setting will be added from the
Paediatric Quality Appraisal Questionnaire (PQAQ) be-
cause this checklist is specially constructed for assessing the
quality of measures for such a population [34]. The quality
assessment will provide a systematic and critical descriptive
overview of key methodological elements. The scoring of
the papers will be divided into 4 categories: poor quality
(scoring 40–55%), good quality (scoring 55–70%), very
good quality (scoring 70–85%) and excellent quality (scor-
ing 85% or higher). To validate the quality assessment
process, the process will be independently checked for
completeness and accuracy by a second reviewer.
Strategy for data synthesis
Following data extraction, the reviewer will provide a narra-
tive synthesis of the results from the included studies,
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structured around general characteristics, characteristics of
the intervention programmes and economic findings (basic
characteristics, study perspectives, resource use, cost
categories, cost-effectiveness findings and sensitivity
analysis), along with a critique of methods used for eco-
nomic evaluation.
Analysis of subgroups or subsets
Subgroup analysis will be considered where deemed
appropriate.
Reporting
The review and its findings will be reported in accord-
ance to the PRISMA guidelines [31]. The strengths and
weaknesses of the methods used for economic evalu-
ation will be discussed. The implications of the review
findings will be discussed within the context of current
and future policy related to obesity.
Discussion and potential impact
Seven recent reviews have summarised the cost-effect-
iveness of obesity prevention and/or treatment interven-
tions in young people; however, none have used or
reported rigorous methods for conducting their reviews.
This comprehensive systematic literature review will pro-
vide a critical review of the methods used in economic
evaluations of child and adolescent obesity and a narrative
summary of reported cost-effectiveness evaluations of pre-
vention and treatment interventions. This critical analysis
of the economic evidence can inform policies for tackling
childhood obesity. We anticipate that the review will also
highlight gaps in the current literature to inform future
economic evaluation research in this area.
Additional files
Additional file 1: PRISMA-P 2015 checklist: recommended items to
include in a systematic review protocol. (DOCX 23 kb)
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